BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26819267)

  • 1. Adverse drug reactions in neonates: a prospective study.
    Belén Rivas A; Arruza L; Pacheco E; Portoles A; Diz J; Vargas E
    Arch Dis Child; 2016 Apr; 101(4):371-6. PubMed ID: 26819267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal profile of adverse drug reactions and associated clinical factors: a prospective observational study in a neonatal intensive care unit.
    Leopoldino RWD; Marques DP; Rocha LC; Fernandes FEM; Oliveira AG; Martins RR
    BMJ Open; 2023 Aug; 13(8):e073304. PubMed ID: 37553191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse drug reactions in neonates hospitalized in neonatal intensive care units in Barranquilla, Colombia].
    De Las Salas R; Díaz-Agudelo D
    Biomedica; 2017 Apr; 37(0):33-42. PubMed ID: 28527264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
    Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
    Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital.
    Remesh A; Balan A; Gnanadurai A
    J Basic Clin Physiol Pharmacol; 2014 Feb; 25(1):125-30. PubMed ID: 24423467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse drug reactions and prescription errors: morbi-mortality].
    Chaio S; Toibaro J; Valicenti P; Saidón P
    Medicina (B Aires); 2013; 73(2):111-8. PubMed ID: 23570758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective identification and causality evaluation of suspected adverse drug reactions in neonates.
    Roberts EK; Hawcutt DB; Turner MA
    Br J Clin Pharmacol; 2021 Mar; 87(3):1541-1546. PubMed ID: 32696451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
    Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
    Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective pharmacovigilance study in the infectious diseases unit of a tertiary care hospital.
    Karaismailoglu B; Saltoglu N; Balkan II; Mete B; Tabak F; Ozturk R
    J Infect Dev Ctries; 2019 Jul; 13(7):649-655. PubMed ID: 32065823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions causing hospital admissions in childhood: a prospective, observational, single-centre study.
    Langerová P; Vrtal J; Urbánek K
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):560-4. PubMed ID: 24810357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
    Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
    Yang W; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.